The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.127.7.888

The authors' review of studies on the teratogenicity of lithium salts during pregnancy revealed conflicting evidence. They believe lithium therapy should be initiated during pregnancy only in severely manic women who are unresponsive to other therapy and for whom continuing manic behavior would jeopardize their own or their babies' lives. They offer six cautions in the use of lithium during pregnancy, including avoidance of diuretics and of salt restriction. In addition, they announce the formation of an American Registry of Lithium Babies.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.